These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11591143)

  • 21. Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse.
    de Silva HV; Más-Oliva J; Taylor JM; Mahley RW
    J Lipid Res; 1994 Jul; 35(7):1297-310. PubMed ID: 7964191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
    Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
    Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between low-density lipoprotein size and apolipoprotein A-I-containing particles: the ECTIM study.
    Luc G; Bard JM; Poulain P; Arveiler D; Evans AE; Cambien F; Fruchart JC; Ducimetière P
    Eur J Clin Invest; 1997 Mar; 27(3):242-7. PubMed ID: 9088861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano).
    Chiesa G; Stoltzfus LJ; Michelagnoli S; Bielicki JK; Santi M; Forte TM; Sirtori CR; Franceschini G; Rubin EM
    Atherosclerosis; 1998 Jan; 136(1):139-46. PubMed ID: 9544740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.
    Chajek-Shaul T; Hayek T; Walsh A; Breslow JL
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6731-5. PubMed ID: 1907375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.
    Wang Y; Niimi M; Nishijima K; Waqar AB; Yu Y; Koike T; Kitajima S; Liu E; Inoue T; Kohashi M; Keyamura Y; Yoshikawa T; Zhang J; Ma L; Zha X; Watanabe T; Asada Y; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):224-31. PubMed ID: 23241412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.
    Warden CH; Hedrick CC; Qiao JH; Castellani LW; Lusis AJ
    Science; 1993 Jul; 261(5120):469-72. PubMed ID: 8332912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo interactions of Triton 1339 with plasma lipoproteins of normolipidemic rhesus monkeys. Preferential effects on high density lipoproteins.
    Yamamoto K; Shen B; Zarins C; Scanu AM
    Arteriosclerosis; 1984; 4(4):418-34. PubMed ID: 6431955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.
    Chan DC; Watts GF; Ooi EM; Chan DT; Wong AT; Barrett PH
    Metabolism; 2011 Oct; 60(10):1482-7. PubMed ID: 21550083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
    Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
    Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
    Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
    J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.
    Cohn JS; Wagner DA; Cohn SD; Millar JS; Schaefer EJ
    J Clin Invest; 1990 Mar; 85(3):804-11. PubMed ID: 2107210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles.
    Iriyama K; Nishiwaki H; Terashima H; Tonouchi H; Miki C; Suzuki H; Carpentier YA
    JPEN J Parenter Enteral Nutr; 1988; 12(1):60-2. PubMed ID: 3125357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on lipid and apolipoprotein composition of plasma VLDL, LDL and HDL in endogenous hypertriglyceridemia].
    Fan P; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):6-10. PubMed ID: 7657341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium deficiency affects plasma lipoprotein composition in rats.
    Gueux E; Mazur A; Cardot P; Rayssiguier Y
    J Nutr; 1991 Aug; 121(8):1222-7. PubMed ID: 1907315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.
    Tani M; Horvath KV; Lamarche B; Couture P; Burnett JR; Schaefer EJ; Asztalos BF
    Atherosclerosis; 2016 Oct; 253():7-14. PubMed ID: 27573733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.